Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Pharm Res. 2011 Oct 20;29(3):770–781. doi: 10.1007/s11095-011-0601-8

Figure 7.

Figure 7

HER2 expression is maintained upon ex vivo culture of lapatinib-treated brain metastatic tumor cells. 231-BR-HER2 cells were injected into immunocompromised mice, treated with either 100 mg/kg lapatinib twice daily or vehicle. At necropsy, tumor cells were cultured ex vivo from brains of lapatinib-treated (L) or vehicle-treated (V) mice. The HER2 expression of lysates of each culture was determined by western blot, using α-tubulin as a loading control.